Notice of Extension for PAR-21-114: NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Pre-Clinical Research (R44 Clinical Trial Not Allowed)
Notice Number:
NOT-NS-24-051

Key Dates

Release Date:

January 5, 2024

Related Announcements

  • January 25, 2021 - NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Pre-Clinical Research (R44 Clinical Trial Not Allowed). See NOFO PAR-21-114.

Issued by

National Institute of Neurological Disorders and Stroke (NINDS)

Purpose

This Notice informs potential applicants that the Key Dates information listed in Notice of Funding Opportunity (NOFO) PAR-21-114, “NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Pre-Clinical Research (R44 Clinical Trial Not Allowed)” has changed. Specifically, the expiration date has been changed from January 6, 2024 to April 6, 2024.

The Key Dates information listed under Part 1. Overview Information of PAR-21-114 was modified as follows:

Key Dates

Previously Read:

Posted Date: January 25, 2021

Open Date (Earliest Submission Date): March 05, 2021

Letter of Intent Due Date(s): 30 days prior to the application due date

Application Due Date(s): Standard dates apply

The first standard due date for this FOA is April 5, 2021

All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

AIDS Application Due Date(s): Not Applicable

*** SBIR/STTR applications are no longer accepted on Standard AIDS Due dates.

Scientific Merit Review: Standard dates apply

Advisory Council Review: Standard dates apply

Earliest Start Date: Standard dates apply

Expiration Date: January 06, 2024

Due Dates for E.O. 12372: Not Applicable

Revised to Read (changes shown in bold italics):

Posted Date: January 25, 2021

Open Date (Earliest Submission Date): March 05, 2021

Letter of Intent Due Date(s): 30 days prior to the application due date

Application Due Date(s): Standard dates apply

The first standard due date for this FOA is April 5, 2021

All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

AIDS Application Due Date(s): Not Applicable

*** SBIR/STTR applications are no longer accepted on Standard AIDS Due dates.

Scientific Merit Review: Standard dates apply

Advisory Council Review: Standard dates apply

Earliest Start Date: Standard dates apply

Expiration Date: April 06, 2024

Due Dates for E.O. 12372: Not Applicable

All other aspects of the NOFO remain unchanged.

Inquiries

Please direct all inquiries to:

Emily Caporello, Ph.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-1778
Email: [email protected]